BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32335082)

  • 1. Dexmedetomidine protects intestinal ischemia-reperfusion injury via inhibiting p38 MAPK cascades.
    Liu XM; Chen QH; Hu Q; Liu Z; Wu Q; Liang SS; Zhang HG; Zhang Q; Zhang XK
    Exp Mol Pathol; 2020 Aug; 115():104444. PubMed ID: 32335082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the P38-MAPK/TXNIP signaling activation in streptozotocin induced diabetic rats.
    Yeda X; Shaoqing L; Yayi H; Bo Z; Huaxin W; Hong C; Zhongyuan X
    Acta Cir Bras; 2017 Jun; 32(6):429-439. PubMed ID: 28700004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
    Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
    J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Gingerol protects intestinal barrier from ischemia/reperfusion-induced damage via inhibition of p38 MAPK to NF-κB signalling.
    Li Y; Xu B; Xu M; Chen D; Xiong Y; Lian M; Sun Y; Tang Z; Wang L; Jiang C; Lin Y
    Pharmacol Res; 2017 May; 119():137-148. PubMed ID: 28167239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway.
    Wang K; Zhu Y
    J Int Med Res; 2018 Feb; 46(2):675-686. PubMed ID: 29210287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice.
    Chen Z; Ding T; Ma CG
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1143-1150. PubMed ID: 28784305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the p38 mitogen-activated protein kinase signaling pathway in estrogen-mediated protection following flap ischemia-reperfusion injury.
    Ju J; Wu J; Hou R
    Cell Biochem Funct; 2016 Oct; 34(7):522-530. PubMed ID: 27748573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits.
    Sun Z; Zhao T; Lv S; Gao Y; Masters J; Weng H
    J Transl Med; 2018 Jul; 16(1):209. PubMed ID: 30031397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol alleviates intestinal ischemia/reperfusion injury in rats through p38 MAPK/NF-κB signaling pathway.
    Li L; Shu F; Wang XQ; Wang F; Cai L; Zhao X; Lv HG
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1574-1581. PubMed ID: 33629346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid mitogen-activated protein kinase by basic fibroblast growth factor in rat intestine after ischemia/reperfusion injury.
    Fu XB; Yang YH; Sun TZ; Chen W; Li JY; Sheng ZY
    World J Gastroenterol; 2003 Jun; 9(6):1312-7. PubMed ID: 12800247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
    Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
    Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of p38 mitogen-activated protein kinase may decrease intestinal epithelial cell apoptosis and improve intestinal epithelial barrier function after ischemia- reperfusion injury.
    Zheng SY; Fu XB; Xu JG; Zhao JY; Sun TZ; Chen W
    World J Gastroenterol; 2005 Feb; 11(5):656-60. PubMed ID: 15655816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
    Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpinetin protects against hepatic ischemia/reperfusion injury in mice by inhibiting the NF-κB/MAPK signaling pathways.
    Pan J; Chen S; Guo W; Cao S; Shi X; Zhang J; Zhang H; Zhang S
    Int Immunopharmacol; 2021 Jun; 95():107527. PubMed ID: 33743314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Hippocampal Neuronal Apoptosis via Inhibiting the p38 MAPK/c-Myc/CLIC4 Signaling Pathway in Rats.
    Chen Y; Li L; Zhang J; Cui H; Wang J; Wang C; Shi M; Fan H
    Mol Neurobiol; 2021 Nov; 58(11):5533-5547. PubMed ID: 34363182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway.
    Zhang Q; Liu XM; Hu Q; Liu ZR; Liu ZY; Zhang HG; Huang YL; Chen QH; Wang WX; Zhang XK
    J Transl Med; 2021 Nov; 19(1):463. PubMed ID: 34772407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramethylpyrazine Inhibits Platelet Adhesion and Inflammatory Response in Vascular Endothelial Cells by Inhibiting P38 MAPK and NF-κB Signaling Pathways.
    Zhang H; Tang W; Wang S; Zhang J; Fan X
    Inflammation; 2020 Feb; 43(1):286-297. PubMed ID: 31720990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine protects against ischemia/reperfusion injury in rat kidney.
    Si YN; Bao HG; Xu L; Wang XL; Shen Y; Wang JS; Yang XB
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1843-51. PubMed ID: 25010612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats.
    Zhang XY; Liu ZM; Wen SH; Li YS; Li Y; Yao X; Huang WQ; Liu KX
    Anesthesiology; 2012 May; 116(5):1035-46. PubMed ID: 22417965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation.
    Si Y; Bao H; Han L; Shi H; Zhang Y; Xu L; Liu C; Wang J; Yang X; Vohra A; Ma D
    J Transl Med; 2013 Jun; 11():141. PubMed ID: 23759023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.